Effects of Oral Tofacitinib on Patient-Reported Outcomes in Patients With Moderate to Severe Crohn's Disease: Results of Two Phase 2B Randomized Placebo-Controlled Trials

被引：0
|
作者：
Panes, Julian
Chan, Gary
Maller, Eric
Moscariello, Michele
Wang, Wenjin
Healey, Paul J.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu2004
引用
收藏
页码：S1003 / S1003
页数：1
相关论文
共 50 条
  • [1] Effects of oral tofacitinib on patient-reported outcomes in patients with moderate-to-severe Crohn's disease: results of 2 Phase 2b randomised placebo-controlled trials
    Panes, J.
    Moscariello, M.
    Maller, E.
    Chan, G.
    Wang, W.
    Healey, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S60 - S61
  • [2] Efficacy and Safety of Tofacitinib for Oral Induction Therapy in Patients With Moderate to Severe Crohn's Disease: Results of a Phase 2B Randomized Placebo-Controlled Trial
    Panes, Julian
    Sandborn, William
    Schreiber, Stefan
    Sands, Bruce E.
    Vermeire, Severine
    Chan, Gary
    Moscariello, Michele
    Wang, Wenjin
    Niezychowski, Wojciech
    Marren, Amy
    Healey, Paul J.
    Maller, Eric
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S182 - S183
  • [3] Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate-to-severe Crohn's disease: results of a Phase 2b randomised placebo-controlled trial
    D'Haens, G.
    Pannaccione, R.
    Higgins, P. D. R.
    Colombel, J. -F.
    Feagan, B. G.
    Moscariello, M.
    Chan, G.
    Healey, P.
    Niezychowski, W.
    Wang, W.
    Marren, A.
    Maller, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S17 - S18
  • [4] Efficacy and safety of oral tofacitinib for induction therapy in patients with moderate-to-severe Crohn's disease: results of a Phase 2b randomised placebo-controlled trial
    Panes, J.
    Sandborn, W. J.
    Schreiber, S.
    Sands, B. E.
    Vermeire, S.
    Chan, G.
    Moscariello, M.
    Wang, W.
    Niezychowski, W.
    Marren, A.
    Healey, P.
    Maller, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S18 - S19
  • [5] Upadacitinib improved patient-reported pruritus in moderate-to-severe atopic dermatitis: results from a phase 2B randomized, placebo-controlled trial
    Hong, C. -H.
    Wu, T.
    Calimlim, B.
    Teixeira, H.
    de Bruin-Weller, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 10 - 10
  • [6] Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis
    Mamolo, C.
    Harness, J.
    Tan, H.
    Menter, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (02) : 192 - 203
  • [7] Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials
    Wallenstein, G. V.
    Kanik, K. S.
    Wilkinson, B.
    Cohen, S.
    Cutolo, M.
    Fleischmann, R.
    Genovese, M. C.
    Gomez Reino, J.
    Gruben, D.
    Kremer, J.
    Krishnaswami, S.
    Lee, E. B.
    Pascual-Ramos, V.
    Strand, V.
    Zwillich, S. H.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 430 - 442
  • [8] Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
    Panes, Julian
    Sandborn, William J.
    Schreiber, Stefan
    Sands, Bruce E.
    Vermeire, Severine
    D'Haens, Geert
    Panaccione, Remo
    Higgins, Peter D. R.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Chan, Gary
    Moscariello, Michele
    Wang, Wenjin
    Niezychowski, Wojciech
    Marren, Amy
    Healey, Paul
    Maller, Eric
    [J]. GUT, 2017, 66 (06) : 1049 - 1059
  • [9] Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials
    Thaci, D.
    Kimball, A.
    Foley, P.
    Poulin, Y.
    Levi, E.
    Chen, R.
    Feldman, S. R.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (03) : 498 - 506
  • [10] Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab
    van Rhee, Frits
    Rothman, Margaret
    Ho, Kai Fai
    Fleming, Sarah
    Wong, Raymond S.
    Fossa, Alexander
    Dispenzieri, Angela
    Cavet, James
    Munshi, Nikhil
    Vermeulen, Jessica
    Casper, Corey
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (02): : 207 - 216
12345